Accepted for/Published in: JMIR Research Protocols
Date Submitted: Mar 29, 2022
Date Accepted: Apr 12, 2022
CVD Prevention Education using a Virtual Environment in Sexual Minority Men of Color with HIV: A Sequential Mixed Methods Wait-list Randomized Control Trial Protocol
ABSTRACT
Background:
It is estimated that 70% of all deaths each year in the United State are due to chronic conditions. Cardiovascular disease, a chronic condition, is the leading cause of death in ethnic and racial males. It has been identified as the second most common cause of death in persons with HIV. By the year 2030, it is estimated that 78% of persons with HIV will be diagnosed with CVD.
Objective:
We propose the first technology-based virtual environment intervention, to address behavioral, modifiable risk factors associated with cardiovascular and metabolic comorbidities in sexual minority men of color with HIV.
Methods:
This study will be guided using Social Cognitive Theory and Technology Acceptance Model. A sequential, mixed method, wait-list control randomized control feasibility trial will be conducted. In Aim 1, we will qualitatively explore perceptions of cardiovascular risk with n=15 participants. In Aim 2, we will conduct a wait-list control to test if a virtual environment is feasible and acceptable for cardiovascular disease prevention using web-based, self-assessed, behavioral and psychosocial outcomes with n=80 sexual minority men of color with HIV.
Results:
The study was approved by the New York University Institutional Review Board in 2019, and also by the Yale University Institutional Review Board in February 2022. Aim 1 data collection is 70% completed and data collection is ongoing. Recruitment for Aim 2 will begin in early April 2022.
Conclusions:
This study will be the first online virtual environment intervention to address CVD prevention in sexual minority men of color with HIV. We anticipate that the intervention will be beneficial for CVD prevention education, building peer social supports, and resulting in a change or modification in CVD-risk behaviors over time. Clinical Trial: ClinicalTrials.gov Identifier: NCT05242952
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.